Publication | Closed Access
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.
1.6K
Citations
0
References
2011
Year
Hematological MalignancyLymphoid NeoplasiaMedicineRandomised Phase 3Follicular LymphomaPathologyOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!